Monday, August 10, 2020

Gufic Biosciences stock rises~2% after application to NCLT for amalgamation of its arm

Gufic Lifesciences and Hetero have agreed to manufacture and supply Remdesivir Lyophilised Powder for injection indicated for emergency use in Covid-19 patients.

from India Infoline News Service https://ift.tt/3agDOLC

No comments:

Post a Comment